Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA-PPQ vs AL for Malaria in Tanzanian Children
NCT01082705Phase 3Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Apr 2010
- Primary completion
- Jun 2011
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in Plasmodium falciparum malaria, sponsored by Centers for Disease Control and Prevention. Started Apr 2010; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01082705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01082705.